Alyeska Investment Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,500
| Closed | -$935K | – | 860 |
|
|
2021
Q1 | $935K | Buy |
+12,500
| New | +$935K | 0.01% | 588 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 602 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 563 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 467 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 474 |
|
|
2019
Q3 | – | Sell |
-31,747
| Closed | -$2.94M | – | 487 |
|
|
2019
Q2 | $2.94M | Buy |
+31,747
| New | +$2.94M | 0.04% | 268 |
|
|
2017
Q2 | – | Sell |
-11,383
| Closed | -$1.81M | – | 544 |
|
|
2017
Q1 | $1.81M | Buy |
11,383
+29
| +0.3% | +$4.62K | 0.01% | 389 |
|
|
2016
Q4 | $1.38M | Buy |
11,354
+90
| +0.8% | +$10.9K | 0.01% | 400 |
|
|
2016
Q3 | $1.56M | Buy |
11,264
+4,264
| +61% | +$591K | 0.01% | 388 |
|
|
2016
Q2 | $1.27M | Buy |
+7,000
| New | +$1.27M | 0.01% | 371 |
|